On the control of late gene expression in Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8)

Journal of General Virology

Volumn 81, Issue 8, 2000, Pages 2039-2047

  Chang, J ^a   Ganem, D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ARTICLE; CELL STRAIN; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; EPSTEIN BARR VIRUS; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; VIRUS ASSEMBLY; VIRUS CORE; VIRUS EXPRESSION; VIRUS GENOME; VIRUS REPLICATION;

DNA VIRUSES; HERPES; HERPESVIRIDAE; HERPESVIRUS 8; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 8; SIMPLEXVIRUS;

EID: 0033895224     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-81-8-2039     Document Type: Article

References (41)

1. Herpes-like sequences in HIV-infected and uninfected Kaposi's sarcoma patients
2. Kaposi's sarcoma among persons with AIDS: A sexually transmitted infection?
3. Kaposi's sarcoma-associated herpesvirus
4. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas
5. Transactivation of a late herpes simplex virus promoter
6. Analysis of the herpes simplex virus type 1 promoter controlling the expression of UL38, a true late gene involved in capsid assembly
7. Propagation of a human herpesvirus from AIDS-associated Kaposi's sarcoma
8. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma
9. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma
10. Regulation of herpesvirus macromolecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins
11. DNA replication is required for abundant expression of a plasmid-borne late US11 gene of herpes simplex virus type 1
12. The control of herpes simplex virus type-1 late gene transcription: A 'TATA-box'/cap site region is sufficient for fully efficient regulated activity
13. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission
14. Regulation of herpes simplex virus true late gene expression: Sequences downstream from the US11 TATA box inhibit expression from an unreplicated template
15. Identification, expression, and immunogenicity of Kaposi's sarcoma-associated herpesvirus-encoded small viral capsid antigen
16. Reactivation of Kaposi's sarcoma-associated herpesvirus infection from latency by expression of the ORF 50 transactivator, a homolog of the EBV R protein
17. Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells
18. Sexual transmission and the natural history of human herpesvirus 8 infection
19. Activation of herpes simplex virus 1 y2 genes by viral DNA replication
20. Delineation of regulatory domains of early (β) and late (y2) genes by construction of chimeric genes expressed in herpes simplex virus 1 genomes
21. Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells
22. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells
23. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection
24. Primary characterization of a herpesvirus agent associated with Kaposi's sarcomae
25. Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma
26. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture
27. Limited transmission of Kaposi's sarcoma-associated herpesvirus in cultured cells
28. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)
29. Late gene expression from the Epstein-Barr virus BcLF1 and BFRF3 promoters does not require DNA replication in cis
30. A functionally distinct TATA box required for late progression through the Epstein-Barr virus life cycle
31. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease
32. Upstream promoter elements of the herpes simplex virus type 1 glycoprotein H gene
33. A viral gene that activates lytic cycle expression of Kaposi's sarcoma-associated herpesvirus
34. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression
35. The protease and the assembly protein of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8)
36. Detection of Kaposi sarcoma-associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma
37. Restricted expression of Kaposi's sarcoma-associated herpesvirus genes in Kaposi's sarcoma